Kestine Lyo (Ebastine)

Ebastine acts as a selective peripheral H1‑receptor antagonist. By blocking histamine binding at these receptors, it prevents the cascade of allergic inflammation that leads to vasodilation, increased vascular permeability, and nerve stimulation, thereby alleviating typical allergy signs without significant central nervous system effects.

The appropriate dose of Kestine Lyo is determined by the prescribing healthcare professional based on the patient’s age, severity of symptoms, and clinical condition. Physicians follow local prescribing guidelines to select the optimal regimen for each individual.

Safety data for ebastine in pregnancy and lactation are limited. Healthcare providers should weigh the potential benefits against possible risks before prescribing Kestine Lyo to pregnant or nursing mothers, and consider alternative therapies when appropriate.

To order Kestine Lyo, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with first‑generation antihistamines, ebastine offers a lower risk of sedation and anticholinergic side effects. Relative to other second‑generation agents such as cetirizine or loratadine, ebastine has a similar efficacy profile but may differ in dosing frequency and metabolic pathways, which can influence drug‑interaction potential.

Kestine Lyo should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in the original container, protect them from moisture and direct sunlight, and ensure they are out of reach of children.

Kestine Lyo is taken orally as a tablet. Patients should swallow the tablet whole with a glass of water, with or without food, as directed by their prescriber.

Serious adverse reactions, although rare, include anaphylactic shock, severe skin reactions such as Stevens‑Johnson syndrome, and significant liver enzyme elevations. Any signs of rash, swelling, difficulty breathing, or jaundice should prompt immediate medical evaluation.

Kestine Lyo is contraindicated in individuals with known hypersensitivity to ebastine or any excipients in the tablet. Caution is advised for patients with severe hepatic impairment, and it should be used only under medical supervision in those with significant liver disease.